Metabolism Disorder TRIZ Cases

Removing pathogenic IgG or blocking its interaction with voltage-gated calcium channels resolves impaired glucose homeostasis and diabetes risk in ALS patients.

PEG hydrogel depot encapsulates GALNS enzyme to extend activity from minutes to seven days, reducing weekly infusion frequency.

A stable anti-PCSK9 antibody formulation uses histidine, sucrose, trehalose, and polysorbate 80 buffers to maintain protein purity.

Segmented diacyl chains form amide bonds with insulin residues, extending half-life while maintaining structural stability against degradation.

Replacing irreversible warheads with reversible binding groups reduces side effects while maintaining MetAP2 inhibition efficacy.

Monitoring C-reactive protein levels resolves uncertainty in statin therapy evaluation by establishing actionable thresholds for clinical decision-making.

Recombinant adeno-associated viral vectors deliver functional methylmalonyl-CoA mutase genes to liver cells.

Antibodies with pH-dependent binding dissociate from PCSK9 in acidic endosomes, reducing antigen-mediated clearance and extending antibody half-life.

Segmented dietary fiber beads in beverages activate oral mechanoreceptors to suppress hunger, overcoming the short-lived efficacy of standard herbal drinks.

Antibody-drug conjugates deliver GLP1 peptidomimetics via non-cleavable linkers, extending duration of action and reducing administration frequency.

Regulating GPx2 expression improves insulin signaling and controls blood glucose without causing hypoglycemia.

Local Factor VII application arrests hemorrhage while avoiding systemic thrombotic complications.

Integrating acid-insoluble pectin into a gelatin matrix eliminates surface roughness and coat integrity failure from traditional film coating processes.

Cysteine-mediated glycosylation modifies insulin analogues to create stable derivatives that resist aggregation.

Antagonist antibodies bind PCSK9 to preserve LDL receptors, lowering blood cholesterol when statins fail.

Amino acid substitutions in oxyntomodulin analogs prevent dipeptidyl peptidase IV cleavage, extending serum half-life for metabolic disorder treatment.

A cellular-based glucometer system correlates blood glucose levels with physical exertion data transmitted via GPRS networks.

An amber extract agent suppresses alpha-glucosidase activity and glucose absorption to delay carbohydrate decomposition.

Weekly intralesional epidermal growth factor injection reduces adverse events and improves adherence in diabetic foot ulcer treatment.

An egg-derived antibody binds digestive enzymes to reduce fat and carbohydrate absorption, addressing obesity risks from excessive caloric intake.

Optimized cyclodextrin complex manufacturing enhances agent bioavailability and stability through precise parameter control.

A calcimimetic peptide acts as a calcium sensing receptor agonist to suppress parathyroid hormone secretion and reduce serum calcium levels.

A standardized Aframomum melegueta seed composition containing 6-paradol, 6-shogaol, and 6-gingerol activates brown adipose tissue to enhance thermogenic energy expenditure.

Pyruvate-based edible compositions resolve the trade-off between therapeutic effectiveness and palatability while reducing inflammation.

Combines probiotics with a vitamin B complex to promote in vivo absorption and synergistically reduce blood lipid concentrations.

Compositions combining toll-like receptor agonists with apoptotic cells to induce targeted TH17 immune responses.

Segmenting dietary proteins into specific polypeptides resolves unclear satiety mechanisms while preventing metabolic syndrome.

Using NGAL and SERPINA3 biomarkers to predict patient responsiveness to mineralocorticoid receptor antagonists, reducing hyperkalemia risk.

Non-viral ceDNA vectors bypass AAV packaging limits and immune responses to sustain GBA expression.

Differentiating human embryonic stem cells into PDX1-positive pancreatic endoderm using staged growth factors.

PBK1 modulators restore beta cell mass and glycemic control by targeting the PBK1 kinase pathway, overcoming progressive beta cell loss in type 2 diabetes.

A charge-switchable polymer complex binds insulin and releases it upon glucose detection.

Polysorbate-80 prevents soluble aggregate formation in GLP-1-Fc fusion protein solutions, ensuring long-term storage stability.

Replacing C-terminal lysine with glycine in dual GLP-1 glucagon agonists improves peptide solubility while maintaining receptor binding affinity.

Specific Bifidobacterium animalis dosing reduces abdominal distension by 50% and alleviates IBS symptoms.

Smad2 inhibitors restore beta cell mass and glucose tolerance by addressing progressive dysfunction.

Double-acylated GLP-1 derivatives attach two protractors to lysine residues 36 and 37, extending terminal half-life beyond daily dosing intervals.

Mangifera indica extract activates SIRT1, resolving slow development of metabolic disease treatments.

Cyclic amino acids at B28 or B29 positions reduce dimer association constants in insulin derivatives.

A biocompatible macromolecular block arranged between pancreatic islet cells sustains glucose sensitivity and insulin production.

Combining cholesterol and glutamine auxotrophy resolves the reliability-productivity trade-off in cell culture systems.

Administering a microbial convener with Methanobrevibacter restores gut microbiome balance, reducing inflammatory bowel disease symptoms.

Recombinant Thbs4 protein activates beige-like changes in white adipose tissue to increase metabolic rate.

Pentacyclic triterpene agents reduce body weight and fat while improving glucose homeostasis without severe side effects.

Replacing the native CGRP carboxy group with an amide reduces enzymatic proteolysis, extending duration of action for metabolic disorder treatment.

Standardizes inulin degree of polymerization below 25 combined with sulfonylureas to ensure predictable blood glucose control while reducing side effects.

Merged IA-2 and pro-insulin peptides suppress autoimmune beta cell destruction, improving blood glucose reliability through antigen-specific regulation.

Cyclic fasting mimicking diets lower hypertension and lipid markers while preventing malnutrition risks from chronic calorie restriction.